http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-922401-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60da379fb33c192ef77f86a60c5ac029
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-446
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
filingDate 1987-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1987-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-922401-L
titleOfInvention An injectable pharmaceutical composition for the¹protectionof tissue damaged by ischemia
abstract "IMPROVED FIBRINOLYTIC COMPOSITION" of the Invention In accordance with the present invention, a composition is provided that is effective in dissolving blood clots and reestablishing and maintaining blood flow through thrombosed coronary or other blood vessels. The fibrinolytic composition of the present invention comprises an enzyme, such as streptokinase, urokinase, tissue plasminogen activator or other fibrinolytic enzyme, and a surface-active copolymer. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula: HO(C2H4O)b(C3H6O)a(C2H4O)bH wherein a is an integer such that the hydrophobe represented by (C3H6O) has a molecular weight of approximately 950 to 4000, preferably approximately 1750 to 3500, and b is an integer such that the hydrophile portion represented by (C2H4O) constitutes approximately 50% to 90% by weight of the compound.n[CA1297792C]
priorityDate 1986-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426149262
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25619
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281408
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403426
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452511974
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15120
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396424
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16227
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100128998
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29598
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04185
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25692
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18792
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24751
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8MHY7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5328
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06869
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID738078
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9815560
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100008445
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05589
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP96471
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5RF29

Total number of triples: 44.